Skip to content
HeyJared

Vikas Dandekar

Reporter · IN

Indexed articles, last 90 days
3
Latest publication
Aug 17, 2026
Outlet visibility, for indiatimes.com
Top 50K sites
Earliest in this view
Jul 24, 2026
The latest indexed work is over 30 days old. There may be a gap in what we hold.

Latest articles

  1. Article · Aug 17, 2026 · Vikas Dandekar

    Are patients paying the price for India’s PE-led healthcare boom? (opens the original)

    Excerpt

    Read excerpt

    Fix hospital room charges at the average tariffs of three-star hotels in metro cities, a parliamentary committee on health and family welfare recently highlighted as part of its 361-page report on the affordability and accessibility of healthcare in India. The panel, while acknowledging the wide variation in hospital charges across the country, stressed the need for better public health infrastructure, capping fees, and strengthening the cadre

  2. Article · Jul 31, 2026 · Vikas Dandekar

    Morning Brief Podcast: No Place to Hide: Inside Maharashtra’s Food & Drug Crackdown (Part 1) | The Economic Times Podcast (opens the original)

    Excerpt · English

    Read excerpt

    THE MORNING BRIEFTUNE IN NOW FOR NEWS & VIEWS No Place to Hide: Inside Maharashtra’s Food & Drug Crackdown (Part 1) Vikas Dandekar | NaN:NaN MIN | July 31, 2026 06:38 AM IST Since late May 2026, Maharashtra has been in the middle of one of its most aggressive food and drug enforcement drives in years — adulterated prasad seized near Shirdi, synthetic milk units shut down, the license of Mumbai’s Parsi Dairy Farm suspended, hospitals pulled up for forcing patients to buy from in-house pharmacies,

  3. Article · Jul 24, 2026 · Vikas Dandekar, Rica Bhattacharyya

    Glenmark Chief on Cracking the Multi-Specific Code | The Economic Times Podcast (opens the original)

    Excerpt · English

    Read excerpt

    THE MORNING BRIEFTUNE IN NOW FOR NEWS & VIEWS Glenmark Chief on Cracking the Multi-Specific Code (ET Online) Glenmark Chief on Cracking the Multi-Specific Code Vikas DandekarRica Bhattacharyya | 31:22 MIN | July 24, 2026 12:06 PM IST Glenmark Chairman and Managing Director Glen Saldanha joins Vikas Dandekar and Rica Bhattacharyya to discuss the company’s 25-year innovation bet, and why it’s finally paying off. At the center is ISB2001, a tri-specific antibody partnered with AbbVie, born out of G

Publishing over time

Last 90 days. Choose a month to open its work.

Recurring subjects

Named in the text we hold. One piece can cover several.

Audience

Top 50K sites

For indiatimes.com, the outlet · Measured Aug 1, 2026

Website popularity band, not a count of readers or article views.

About this data

Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.

Identity or attribution wrong? Suggest a correction.

See coverage about Vikas Dandekar